Table 2

Organochlorine concentrations in mother's serum lipids in late pregnancy and infant exposure from mother's milka

Exposure
Study groups


Serumb
Infections
White blood cells
Lymphocyte subsets

CB 28+52+101
4 (3–427)
4 (3–427)
4 (3–19)
CB-153
60 (23–179)
57 (23–158)
59 (23–158)
Di-ortho PCB
131 (44–362)
127 (44–342)
129 (44–342)
Mono-ortho PCB TEQ
4 (1–20)
4 (1–11)
4 (1–9)
p,p'-DDE
88 (21–622)
85 (24–622)
83 (29–622)

Mother's milk exposurec




CB 28+52+101
8 (0–155)
8 (0–76)
9 (0–39)
CB-153
187 (0–853)
174 (0–396)
186 (0–396)
Di-ortho PCB
364 (0–1666)
351 (0–830)
372 (0–830)
Mono-ortho PCB TEQ
11 (0–54)
11 (0–26)
11 (0–26)
p,p'-DDE
311 (0–2199)
289 (0–2199)
306 (0–2199)

aMedian (range). Di-ortho PCB = CB-138, CB-153, CB-180; Mono-ortho PCB TEQ = CB-105, CB-118, CB-156, CB-167 [32]. The study group "Infections" consists of all study participants (prenatal exposure N = 190; postnatal exposure N = 175), the "White blood cells" group is a subgroup of infants among the study participants which had their WBC counts analyzed (N = 86), and within this subgroup lymphocyte subsets were analyzed in the "Lymphocyte" group composed of infants with enough blood left after WBC count analysis (N = 52).

bng/g lipid. Mono-ortho PCBs: pg TEQ/g lipid [32]. Serum sampled week 32–34.

cng/g fresh weight*days. Mono-ortho PCBs: pg TEQ/g fresh weight*days. Calculated as organochlorine concentration in mother's milk on a fresh weight basis*days of nursing*(%of full nursing/100).

Glynn et al. Environmental Health 2008 7:62   doi:10.1186/1476-069X-7-62